$17.76
STAAR Surgical Company


Performance
Dividends
1W
1M
YTD
1Y
3Y
9/36
Growth
Score
8/36
Dividend
Score
Valuation
PE Ratio
-12.33
PS Ratio
3.15
RSI
-
0
PEG Ratio
0
0
PRG Ratio
-0.37
PDG Ratio
0
Growth
2023
2024
2025*
2026*
3
Revenue
Revenue
*Analyst estimated growth
Fundamentals
2
Rule
of 40
48.35%
2
Gross Margin
74%
3
Current Ratio
4.78
Return on Assets
-15.54%
Return on Equity
-17.94%
Return on inv. Capital
-20%
Institutional Holder
Shares
Holders
Financials
Yealy
Quarterly
Revenue 2024 313.90M
2018
2020
2021
2021
2022
2023
2024
6
Net Income 2024 -20.21M
2018
2020
2021
2021
2022
2023
2024
6
Gross Profit 2024 239.58M
2018
2020
2021
2021
2022
2023
2024
6
Events

STAA
STAAR Surgical Company
in 265 days
after market close
Earnings per Share is expected with - and revenue with - .

STAA
STAAR Surgical Company
in 180 days
after market close
Earnings per Share is expected with - and revenue with - .

STAA
STAAR Surgical Company
in 76 days
after market close
Earnings per Share is expected with - and revenue with - .
About
Sector/Industry
Healthcare
Medical - Instruments & Supplies
IPO Date
24.02.1992
MaketCap
879.58M
Country
US
CEO
Stephen C. Farrell CFA
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Updated 04.08.2025